“…In other words, biotechnology firms are understood to be originators of technology, which is then eventually brought to the marketplace by strategic alliance partners with extensive marketing organizations and experience in managing the clinical trials process (e.g., Barley et al, 1992;Rothaermel, 2001;Rothaermel and Deeds, 2004;Robinson and Stuart, 2007). This is a fair characterization of many alliances in the industry.…”